Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Biomerica (BMRAResearch Report) with bullish sentiments.

Biomerica (BMRA)

Aegis Capital analyst Aegis Capital Corp. initiated coverage with a Buy rating on Biomerica yesterday and set a price target of $10.00. The company’s shares closed last Friday at $7.72.

Biomerica has an analyst consensus of Moderate Buy, with a price target consensus of $10.50.

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.